BACTELIDE

AXP000238.1 · Phage therapy

Platform
phage-loaded microcapsule spray
Originator
Precisio Biotix Therapeutics
Sponsor
Precisio Biotix Therapeutics

Names

NameTypeSource
BACTELIDEpreferred name, brandcurator, ctgov
PL-03-BMcodectgov

Virus

Role
Phage
Family
Caudoviricetes
Virus
bacteriophage cocktail against S. aureus, P. aeruginosa and K. pneumoniae
Replication
replicating
Route
topical
Source
evidence

Approvals

No regulatory approval recorded.

Clinical trials (1)

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditions
NCT04815798Phage Therapy for the Prevention and Treatment of Pressure Ulcers.UnknownPhase 1/22022-012023-0869Pressure Ulcer

Recent changes

No changes recorded in its trials yet.

Notes

Bacteriophage-loaded microcapsule spray for colonised pressure injuries (S. aureus, P. aeruginosa, K. pneumoniae); phase 1/2a NCT04815798. The registration also calls it PL-03-BM.

How to cite

BACTELIDE (AXP000238.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000238.html

Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.